193 related articles for article (PubMed ID: 20067553)
21. MicroRNA-206 Reduces Osteosarcoma Cell Malignancy
Zhan FB; Zhang XW; Feng SL; Cheng J; Zhang Y; Li B; Xie LZ; Deng QR
Yonsei Med J; 2019 Feb; 60(2):163-173. PubMed ID: 30666838
[TBL] [Abstract][Full Text] [Related]
22. Phosphorylation of BRN2 modulates its interaction with the Pax3 promoter to control melanocyte migration and proliferation.
Berlin I; Denat L; Steunou AL; Puig I; Champeval D; Colombo S; Roberts K; Bonvin E; Bourgeois Y; Davidson I; Delmas V; Nieto L; Goding CR; Larue L
Mol Cell Biol; 2012 Apr; 32(7):1237-47. PubMed ID: 22290434
[TBL] [Abstract][Full Text] [Related]
23. Regulation of the microphthalmia-associated transcription factor gene by the Waardenburg syndrome type 4 gene, SOX10.
Verastegui C; Bille K; Ortonne JP; Ballotti R
J Biol Chem; 2000 Oct; 275(40):30757-60. PubMed ID: 10938265
[TBL] [Abstract][Full Text] [Related]
24. PAX3 expression in primary melanomas and nevi.
Plummer RS; Shea CR; Nelson M; Powell SK; Freeman DM; Dan CP; Lang D
Mod Pathol; 2008 May; 21(5):525-30. PubMed ID: 18327212
[TBL] [Abstract][Full Text] [Related]
25. Transcriptional regulation of RET by Nkx2-1, Phox2b, Sox10, and Pax3.
Leon TY; Ngan ES; Poon HC; So MT; Lui VC; Tam PK; Garcia-Barcelo MM
J Pediatr Surg; 2009 Oct; 44(10):1904-12. PubMed ID: 19853745
[TBL] [Abstract][Full Text] [Related]
26. Regulation of melanocyte pivotal transcription factor MITF by some other transcription factors.
Wan P; Hu Y; He L
Mol Cell Biochem; 2011 Aug; 354(1-2):241-6. PubMed ID: 21519923
[TBL] [Abstract][Full Text] [Related]
27. PAX3 and FOXD3 Promote CXCR4 Expression in Melanoma.
Kubic JD; Lui JW; Little EC; Ludvik AE; Konda S; Salgia R; Aplin AE; Lang D
J Biol Chem; 2015 Sep; 290(36):21901-14. PubMed ID: 26205821
[TBL] [Abstract][Full Text] [Related]
28. Targeting Pan-ETS Factors Inhibits Melanoma Progression.
Huang L; Zhai Y; La J; Lui JW; Moore SPG; Little EC; Xiao S; Haresi AJ; Brem C; Bhawan J; Lang D
Cancer Res; 2021 Apr; 81(8):2071-2085. PubMed ID: 33526511
[TBL] [Abstract][Full Text] [Related]
29. How Neural Crest Transcription Factors Contribute to Melanoma Heterogeneity, Cellular Plasticity, and Treatment Resistance.
Wessely A; Steeb T; Berking C; Heppt MV
Int J Mol Sci; 2021 May; 22(11):. PubMed ID: 34071193
[TBL] [Abstract][Full Text] [Related]
30. GSK-3 promotes cell survival, growth, and PAX3 levels in human melanoma cells.
Kubic JD; Mascarenhas JB; Iizuka T; Wolfgeher D; Lang D
Mol Cancer Res; 2012 Aug; 10(8):1065-76. PubMed ID: 22679108
[TBL] [Abstract][Full Text] [Related]
31. MITF depletion elevates expression levels of ERBB3 receptor and its cognate ligand NRG1-beta in melanoma.
Alver TN; Lavelle TJ; Longva AS; Øy GF; Hovig E; Bøe SL
Oncotarget; 2016 Aug; 7(34):55128-55140. PubMed ID: 27391157
[TBL] [Abstract][Full Text] [Related]
32. Mechanisms contributing to differential regulation of PAX3 downstream target genes in normal human epidermal melanocytes versus melanoma cells.
Bartlett D; Boyle GM; Ziman M; Medic S
PLoS One; 2015; 10(4):e0124154. PubMed ID: 25880082
[TBL] [Abstract][Full Text] [Related]
33. Validation of met as a therapeutic target in alveolar and embryonal rhabdomyosarcoma.
Taulli R; Scuoppo C; Bersani F; Accornero P; Forni PE; Miretti S; Grinza A; Allegra P; Schmitt-Ney M; Crepaldi T; Ponzetto C
Cancer Res; 2006 May; 66(9):4742-9. PubMed ID: 16651427
[TBL] [Abstract][Full Text] [Related]
34. Determination of transcription factors and their possible roles in the regulation of Pax3 gene expression in the mouse B16 F1 melanoma cell line.
Zhu BK; Pruitt SC
Melanoma Res; 2005 Oct; 15(5):363-73. PubMed ID: 16179863
[TBL] [Abstract][Full Text] [Related]
35. Epistatic relationship between Waardenburg syndrome genes MITF and PAX3.
Watanabe A; Takeda K; Ploplis B; Tachibana M
Nat Genet; 1998 Mar; 18(3):283-6. PubMed ID: 9500554
[TBL] [Abstract][Full Text] [Related]
36. A gene regulatory network combining Pax3/7, Sox10 and Mitf generates diverse pigment cell types in medaka and zebrafish.
Miyadai M; Takada H; Shiraishi A; Kimura T; Watakabe I; Kobayashi H; Nagao Y; Naruse K; Higashijima SI; Shimizu T; Kelsh RN; Hibi M; Hashimoto H
Development; 2023 Oct; 150(19):. PubMed ID: 37823232
[TBL] [Abstract][Full Text] [Related]
37. The myelin protein PMP2 is regulated by SOX10 and drives melanoma cell invasion.
Graf SA; Heppt MV; Wessely A; Krebs S; Kammerbauer C; Hornig E; Strieder A; Blum H; Bosserhoff AK; Berking C
Pigment Cell Melanoma Res; 2019 May; 32(3):424-434. PubMed ID: 30506895
[TBL] [Abstract][Full Text] [Related]
38. The E3 ligase APC/C(Cdh1) promotes ubiquitylation-mediated proteolysis of PAX3 to suppress melanocyte proliferation and melanoma growth.
Cao J; Dai X; Wan L; Wang H; Zhang J; Goff PS; Sviderskaya EV; Xuan Z; Xu Z; Xu X; Hinds P; Flaherty KT; Faller DV; Goding CR; Wang Y; Wei W; Cui R
Sci Signal; 2015 Sep; 8(392):ra87. PubMed ID: 26329581
[TBL] [Abstract][Full Text] [Related]
39. Pax3 is required for enteric ganglia formation and functions with Sox10 to modulate expression of c-ret.
Lang D; Chen F; Milewski R; Li J; Lu MM; Epstein JA
J Clin Invest; 2000 Oct; 106(8):963-71. PubMed ID: 11032856
[TBL] [Abstract][Full Text] [Related]
40. SOX10 immunostaining distinguishes desmoplastic melanoma from excision scar.
Ramos-Herberth FI; Karamchandani J; Kim J; Dadras SS
J Cutan Pathol; 2010 Sep; 37(9):944-52. PubMed ID: 20653825
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
